 INDIANAPOLIS, July 06, 2022 GLOBE NEWSWIRE -- POINT Biopharma Global Inc. NASDAQ: PNT the Company or POINT, a company accelerating the discovery, development and global access to life-changing radiopharmaceuticals, will participate in the following upcoming investor conferences: 